These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4431057)

  • 41. Cell loss from several types of solid murine tumour: comparison of 125I-iododeoxyuridine and tritiated thymidine methods.
    Begg AC
    Cell Tissue Kinet; 1977 Sep; 10(5):409-27. PubMed ID: 922795
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor cells from tumor-bearing mice.
    Glaser M; Kirchner H; Holden HT; Herberman RB
    J Natl Cancer Inst; 1976 Apr; 56(4):865-7. PubMed ID: 1255803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell transfer studies on the persistence of homograft sensitivity in the mouse: in vitro and in vivo correlates of the activity of sensitised lymph node cells.
    Warren J; Gowland G
    J Pathol; 1974 Oct; 114(2):101-11. PubMed ID: 4613807
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells.
    Todd RF; Stulting RD; Berke G
    Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536
    [No Abstract]   [Full Text] [Related]  

  • 45. Studies on purification of antibodies against tumor-specific antigens.
    Park MM
    Pahlavi Med J; 1978 Jan; 9(1):1-26. PubMed ID: 652378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody-induced changes in expression of the H-2 antigen.
    Lesley J; Hyman R
    Eur J Immunol; 1974 Nov; 4(11):732-9. PubMed ID: 4426331
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
    Ting CC; Nunn ME; Park JY; Herberman RB
    J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro tumor cell destruction by syngeneic mouse macrophoages: methods for assaying cytotoxicity.
    Norbury KC; Fidler IJ
    J Immunol Methods; 1975 Apr; 7(1):109-22. PubMed ID: 1123549
    [No Abstract]   [Full Text] [Related]  

  • 49. [Antibodies to the autologous tumor cells in tumor induction in mice using methylcholanthrene].
    Vetrova EP; Fedorovskaia MI; Kaminskaia LP; Umanskiĭ IuA
    Vopr Onkol; 1974; 20(3):59-62. PubMed ID: 4612978
    [No Abstract]   [Full Text] [Related]  

  • 50. Spontaneous release of cytotoxic alloantibody from viable cells sensitized in excess antibody.
    Chang S; Stockert E; Boyse EA; Hämmerling U; Old LJ
    Immunology; 1971 Nov; 21(5):829-38. PubMed ID: 4940171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumorigenicity and isoimmunizing properties of C3H mouse cells undergoing "spontaneous" malignant conversion in vitro.
    Kieler J; Radzikowski C; Moore J; Ulrich K
    J Natl Cancer Inst; 1972 Feb; 48(2):393-405. PubMed ID: 4652381
    [No Abstract]   [Full Text] [Related]  

  • 52. Ascitic versus solid growth of Ehrlich ascites tumor influenced by immunological factors.
    Culo F; Allegretti N; Marusić M
    Oncology; 1978; 35(1):15-21. PubMed ID: 625393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphocyte populations participating in cellular antitumor immune responses mediated by immune RNA.
    Kern DH; Chow N; Pilch YH
    J Natl Cancer Inst; 1978 Feb; 60(2):335-44. PubMed ID: 304487
    [No Abstract]   [Full Text] [Related]  

  • 54. Cytotoxicity in vitro by products of specifically stimulated spleen cells: susceptibility of tumor cells and normal cells.
    Meltzer MS; Bartlett GL
    J Natl Cancer Inst; 1972 Nov; 49(5):1439-43. PubMed ID: 4568090
    [No Abstract]   [Full Text] [Related]  

  • 55. Embryonic antigens shared between chemically induced lymphosarcomas and fibrosarcomas of the mouse.
    Ménard S; Colnaghi MI
    J Natl Cancer Inst; 1975 Feb; 54(2):479-81. PubMed ID: 1172784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The specificity of concomitant tumor immunity at large tumor volumes.
    Deckers PJ; Pardridge DH; Wang BS; Mannick JA
    Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody-induced changes in expression of an immunoglobulin surface antigen.
    Knopf PM; Destree A; Hyman R
    Eur J Immunol; 1973 May; 3(5):351-9. PubMed ID: 4758896
    [No Abstract]   [Full Text] [Related]  

  • 58. Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumors.
    Civin CI; Dorfman N; Eggers A; Fink K; Penvose D; Hsu CK; Wunderlich JR
    J Immunol; 1979 Dec; 123(6):2550-7. PubMed ID: 159318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induced resistance in normal mice and growth enhancement in tumor-bearing mice by inoculation with syngeneic hybrid cells.
    Dei T; Tachibana T
    J Natl Cancer Inst; 1980 Oct; 65(4):739-49. PubMed ID: 6448309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distribution of radiolabeled alloantibodies in mice bearing 3-methylcholanthrene-induced sarcoma.
    Buchsbaum DJ; Walker PC; Johnson EA
    Cancer Res; 1979 Sep; 39(9):3363-8. PubMed ID: 476667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.